Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

What is the cost of lung cancer in Germany?

01.10.2015

With more than 50,000 newly diagnosed cases each year, lung cancer is one of the most common types of cancer in Germany. As yet, however, very few statistics are available on the care situation of lung cancer sufferers and the associated costs. Scientists at the Helmholtz Zentrum München have now analyzed comprehensive health insurance data in order to discover the cost of the disease and which treatment has the best prognosis. Their findings have been published in the medical journal Lung Cancer.

As part of their research, the team of scientists headed by Dr. Larissa Schwarzkopf and Prof. Reiner Leidl from the Institute of Health Economics and Health Care Management examined data from more than 17.000 lung cancer patients (approx. 12.000 men and about 5.000 women). “Our results are based on national performance data provided by the AOK (the biggest German SHI Fund, which covers about one third of the resident population). Cases of lung cancer which occurred in 2009 were recorded and their development was then observed over a three-year period,” explains first author Larissa Schwarzkopf. In the process, the scientists recorded operations as well as chemotherapy and radiation treatments.


Dr. Larissa Schwarzkopf and Prof. Reiner Leidl

Source: Helmholtz Zentrum München (HMGU)

20.000 euros per patient

The Helmholtz researchers, who are also affiliated to the German Center for Lung Research (DZL), discovered that the highest costs were incurred in the first six months after the initial cancer diagnosis. These were mainly attributable to in-patient hospital care. Consequently, outpatient oncology care played a secondary role. Average financial expenditure per case of lung cancer amounted to about 20.000 euros. However, this amount varied immensely, depending on the type of treatment provided. The striking feature was that one fifth of patients did not receive targeted cancer therapy.

Surgery offers the best outlook

Overall, the scientists found that about one third of patients received surgery. When compared with other types of treatment such as radiation therapy or chemotherapy (undergone by a total of just under 47 per cent of those affected by the disease), the outlook for this group was significantly better. However, the experts pointed out that surgical intervention is not always possible, nor is it always appropriate. In their view, there is therefore an urgent and growing need to develop more refined methods of early cancer detection in order to increase the chances of diagnosing the disease while it is still operable.

“These results mark the first step towards a better understanding of the health care and cost structures relating to lung cancer in Germany, and they are an important reference point,” says Reiner Leidl. “In order to obtain a better assessment of the realities of health care it would also be beneficial to conduct a more precise analysis of the drug therapy used.” For this purpose, the scientists plan to gather more data. Drug therapy in oncology is undergoing constant change, Larissa Schwarzkopf says. “It was only at the end of the study period that modern targeted therapeutic approaches such as monoclonal antibodies were integrated into health care. These approaches play an increasingly important role – in both therapeutic and economic terms. In future it would make sense to conduct a comparison with our reference data.”

Further information

Background
* While spending on radiotherapy and surgery (Per case over a three-year timeframe) amounted to about 26,000 and 20,000 euros respectively, there were also some patients who did not receive any specific therapy and whose treatment only cost 4,200 euros. For each year that the patients survived, average costs totaled 15,000 euros.

Original publication:
Schwarzkopf, l. et al. (2015). Cost-components of lung cancer care within the first three years after initial diagnosis in the context of different treatment regimens, Lung Cancer, DOI: 10.1016/j.lungcan.2015.09.005

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. http://www.helmholtz-muenchen.de/en/index.html

The Institute of Health Economics and Health Care Management (IGM) examines approaches to improving the efficiency and cost-effectiveness of health care. The health care system faces the challenge of delivering high-quality, economically viable medical services to meet the needs of the population. Rapid advances in medical technology and fast-changing demographics further aggravate this problem. A firmly based evaluation of the effectiveness and efficiency of health care structures and processes is therefore an essential prerequisite for a rational health care policy. http://www.helmholtz-muenchen.de/en/igm/index.html

The German Center for Lung Research (DZL) is a national association that pools German expertise in the field of pulmonary research and coordinates basic research, epidemiology and clinical application. The DZL has five coordinating centers located in Borstel/Lübeck/Kiel/Grosshansdorf, Giessen/Marburg/Bad Nauheim, Hanover, Heidelberg and Munich. The goal of the DZL is to find answers to open questions in research into lung diseases by adopting an innovative, integrated approach and thus to make a sizeable contribution towards improving the prevention, diagnosis and treatment of lung diseases. http://www.dzl.de/index.php/de/

Contact for the media:
Department of Communication, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49 89 3187 2238 - Fax: +49 89 3187 3324 – E-mail: presse@helmholtz-muenchen.de

Scientific contact at Helmholtz Zentrum München:
Dr. Larissa Schwarzkopf, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management, Research Group Economics and Management of Lung Diseases, Ingolstädter Landstr. 1, 85764 Neuherberg – Phone: +49 89 3187 3994 – E-mail: l.schwarzkopf@helmholtz-muenchen.de

Weitere Informationen:

http://www.sciencedirect.com/science/article/pii/S0169500215300490 - Link to the original publication

Kommunikation | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

Further reports about: Environmental Health Umwelt diseases health care lung cancer lung diseases

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>